Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Announcement of extension of joint research agreement with University of Fukui for the development of novel cataract treatments
Announcement of extension of joint research agreement with University of Fukui for the development of novel cataract treatments
Announcement of the results of joint research with RaQualia Pharma Inc.
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Three Months Ended March 31, 2025 (Based on Japanese GAAP)
[Delayed]Announcement of patent grant for diagnostic agent for retinopathy of prematurity and related conditions by our consolidated subsidiary
Presentation at ARVO2025
Announcement of joint research agreement with Mie University for the development of new drugs for lifestyle-related diseases targeting our compounds
Announcement of the commencement of joint research on next-generation drug development for the creation of new eye disease treatments
FDA Acceptance of New Drug Application for DW-5LBT
Corporate Governance Report March 25,2025
Consolidated Financial Results for the Fiscal Year Ended December 31, 2024 (Based on Japanese GAAP)
FY12/24 Financial Results Briefing Materials
Consolidated Financial Results for the Nine Months Ended September 30, 2024 (Based on Japanese GAAP)